Internal Medicine Alert – October 30, 2008
October 30, 2008
View Issues
-
New Hope for COPD?
Inhaled salmeterol and fluticasone, singly or in combination, reduce the rate of decline of the FEV1 in patients with moderate-to-severe COPD. -
CT Colonographic Screening: Does the Technique Merit Widespread Adoption?
CT colonographic screening of asymptomatic adults identified 90% of polyps or cancers measuring 10 mm or more. -
Intensive Glucose Lowering: Too Much of a Good Thing?
Intensive hemoglobin A1c lowering does not reduce the rate of cardiovascular death, and results in an increase in hypoglycemic events. -
Clinical Briefs by Louis Kuritzky, MD
Homocysteine (HCYS) has all the trappings of a first-rate cardiovascular risk factor: as strong an association with CVD endpoints as cholesterol, ease of identification, and simplicity of modulation. Trouble is, trials to date have been unable to show that reductions of homocysteine provide meaningful benefits to patients.